Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cystic fibrosis: desensitization in delayed hypersensitivity reactions to elexacaftor/tezacaftor/ivacaftor.

Frontiers in pharmacology·2024
Same author

Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial.

Physiotherapy·2015
Same author

Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011
Same author

Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients.

The European respiratory journal·2011
Same author

Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic.

The European respiratory journal·2010
Same author

VAP surveillance: role of non-quantitative culture of endotracheal aspirates (NQC-ETA).

Minerva anestesiologica·2010
Same journal

Rectus sheath block for analgesia in open abdominal surgery: a systematic review, meta-analysis and trial sequential analysis.

Minerva anestesiologica·2026
Same journal

Highlights from the June 2026 issue.

Minerva anestesiologica·2026
Same journal

Validation of the Gendolcat model for chronic postsurgical pain after cesarean section: a multicenter study.

Minerva anestesiologica·2026
Same journal

Dual block strategy for complex incision in pediatric kidney transplantation: M-TAPA and quadroiliac plane block combination.

Minerva anestesiologica·2026
Same journal

Technical note: a novel fully visualized, glottic-sparing strategy for infant one-lung ventilation.

Minerva anestesiologica·2026
Same journal

Ultrasound-guided recto-intercostal fascial plane block facilitating early extubation following pediatric subxiphoid pericardial window surgery.

Minerva anestesiologica·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Community-acquired pneumonia.

E Polverino1, A Torres Marti

  • 1Pneumology Department, Clinic Institute of Thorax (ICT), Hospital Clinic of Barcelona, August Pi i Sunyer (IDIBAPS) Biomedical Investigation Institute, Barcelona, Spain.

Minerva Anestesiologica
|January 19, 2011
PubMed
Summary
This summary is machine-generated.

Community-acquired pneumonia (CAP) remains a leading cause of death globally, despite medical advances. This overview covers CAP

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Experiment Videos

Last Updated: Jun 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Area of Science:

  • Medicine
  • Public Health
  • Infectious Diseases

Background:

  • Community-acquired pneumonia (CAP) persists as a major global cause of mortality.
  • Significant advances in treatment and care have not reduced CAP-related deaths.
  • CAP imposes a substantial clinical and economic burden, especially on vulnerable populations like children and the elderly.

Purpose of the Study:

  • To provide a comprehensive clinical overview of community-acquired pneumonia.
  • To focus on key aspects including epidemiology, diagnosis, treatment, and prevention.
  • To analyze challenges in CAP management, including treatment resistance and adjunctive therapies.

Main Methods:

  • Review of current literature and clinical guidelines on community-acquired pneumonia.
  • Analysis of epidemiological data and economic impact assessments.
  • Discussion of diagnostic tools, biomarkers, and therapeutic strategies.

Main Results:

  • CAP continues to be a significant public health challenge with high mortality rates.
  • Effective diagnosis and risk stratification are crucial for optimal patient outcomes.
  • A multifaceted approach involving antimicrobial and non-antibiotic therapies is essential for managing CAP.

Conclusions:

  • Despite advances, CAP management requires continuous improvement in diagnosis, treatment, and prevention strategies.
  • Understanding microbial etiology and utilizing biomarkers can guide therapy.
  • Addressing treatment non-response is critical for improving clinical outcomes in CAP patients.